Publication Cover
Structural Heart
The Journal of the Heart Team
Volume 2, 2018 - Issue 6
103
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Impact of Transcatheter Mitral Valve Repair on Left Ventricular Remodeling in Secondary Mitral Regurgitation: A Meta-Analysis

ORCID Icon, , , , , , , MDORCID Icon, , , , , & show all
Pages 541-547 | Received 04 May 2018, Accepted 23 Aug 2018, Published online: 17 Oct 2018

References

  • Barth S , Hautmann MB , Kerber S , et al. Left ventricular ejection fraction of  < 20%: Too bad for MitraClip©? Catheter Cardiovasc Interv . 2017;90(6):1038–1045. doi:10.1002/ccd.27159.
  • Baskett RJ , Exner DV , Hirsch GM , Ghali WA. Mitral insufficiency and morbidity and mortality in left ventricular dysfunction. Can J Cardiol . 2007;23:797–800.
  • Agricola E , Ielasi A , Oppizzi M , et al. Long‐term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail . 2009;11(6):581–587. doi:10.1093/eurjhf/hfp051.
  • Rossi A , Dini FL , Faggiano P , et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart . 2011;97(20): 225789.
  • Nishimura RA , Otto CM , Bonow RO , et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol . 2017;70(2):252–89.
  • Mirabel M , Iung B , Baron G , et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J . 2007;28(11):1358–1365. doi:10.1093/eurheartj/ehm001.
  • Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM . Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol . 2005;45(3):381–387. doi:10.1016/j.jacc.2004.09.073.
  • Berardini A , Biagini E , Saia F , et al. Percutaneous mitral valve repair: the last chance for symptoms improvement in advanced refractory chronic heart failure? Int J Cardiol . 2017;228:191–197. doi:10.1016/j.ijcard.2016.11.241.
  • Gripari P , Tamborini G , Bottari V , et al. Three-dimensional transthoracic echocardiography in the comprehensive evaluation of right and left heart chamber remodeling following percutaneous mitral valve repair. J Am Soc Echocardiogr . 2016;29(10):946–954. doi:10.1016/j.echo.2016.06.009.
  • Scandura S , Ussia GP , Capranzano P , et al. Left cardiac chambers reverse remodeling after percutaneous mitral valve repair with the MitraClip system. J Am Soc Echocardiogr . 2012;25(10):1099–1105. doi:10.1016/j.echo.2012.07.015.
  • Stroup DF , Berlin JA , Morton SC , et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA . 2000;283:2008–2012.
  • Moher D , Liberati A , Tetzlaff J , Altman DG , Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med . 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
  • Wells G , Ga W , Shea B , et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2012.Department of Epidemiology and Community Medicine, University of Ottawa, Canada. Available at: www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • Higgins JP , Thompson SG , Deeks JJ , Altman DG . Measuring inconsistency in meta-analyses. BMJ: Br Med J . 2003;327(7414):557. doi:10.1136/bmj.327.7414.557.
  • Egger M , Smith GD , Schneider M , Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ . 1997;315:629–634.
  • Braun D , Lesevic H , Orban M , et al. Percutaneous edge‐to‐edge repair of the mitral valve in patients with degenerative versus functional mitral regurgitation. Catheter Cardiovasc Interv . 2014;84(1):137–146. doi:10.1002/ccd.25331.
  • Giaimo VL , Zappulla P , Cirasa A , et al. Long‐term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization. Pacing Clin Electrophysiol . 2018;41(1):65–72. doi:10.1111/pace.13241.
  • Grayburn PA , Foster E , Sangli C , et al. Relationship Between the Magnitude of Reduction in Mitral Regurgitation Severity and Left Ventricular and Left Atrial Reverse Remodeling After Mitraclip Therapy. Circulation . 2013;128(15):1667–74.
  • Godino C , Salerno A , Cera M , et al. Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation. IJC Heart & Vasculature . 2016;11:90–98. doi:10.1016/j.ijcha.2016.05.017.
  • Pighi M , Estevez-Loureiro R , Maisano F , et al. Immediate and 12-month outcomes of ischemic versus nonischemic functional mitral regurgitation in patients treated with MitraClip (from the 2011 to 2012 pilot sentinel registry of Percutaneous edge-to-edge mitral valve repair of the European Society of Cardiology). Am J Cardiol . 2017;119(4):630–637. doi:10.1016/j.amjcard.2016.10.049.
  • De Bonis M , Taramasso M , Lapenna E , et al. MitraClip therapy and surgical edge-to-edge repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: mid-term results of a single-centre experience. Eur J Cardiothorac Surg . 2015;49(1):255–262. doi:10.1093/ejcts/ezv043.
  • Melisurgo G , Ajello S , Pappalardo F , et al. Afterload mismatch after MitraClip insertion for functional mitral regurgitation. Am J Cardiol . 2014;113(11):1844–1850. doi:10.1016/j.amjcard.2014.03.015.
  • Vitarelli A , Mangieri E , Capotosto L , et al. Assessment of biventricular function by three-dimensional speckle-tracking echocardiography in secondary mitral regurgitation after repair with the MitraClip system. J Am Soc Echocardiogr . 2015;28(9):1070–1082. doi:10.1016/j.echo.2015.04.005.
  • Giannini C , Petronio AS , De Carlo M , et al. Integrated reverse left and right ventricular remodelling after MitraClip implantation in functional mitral regurgitation: an echocardiographic study. Eur Heart J Cardiovasc Imaging . 2013;15(1):95–103. doi:10.1093/ehjci/jet141.
  • Chan PH , She HL , Alegria-Barrero E , Moat N , Di Mario C , Franzen O . Real-world experience of MitraClip for treatment of severe mitral regurgitation. Circ J . 2012;76:2488–2493.
  • Franzen O , Heyden J , Baldus S , et al. MitraClip® therapy in patients with end‐stage systolic heart failure. Eur J Heart Fail . 2011;13(5):569–576. doi:10.1093/eurjhf/hfr029.
  • Taramasso M , Maisano F , Latib A , et al. Clinical outcomes of MitraClip for the treatment of functional mitral regurgitation. EuroIntervention . 2014;10(6):746–752. doi:10.4244/EIJV10I6A128.
  • Nickenig G , Estevez-Loureiro R , Franzen O , et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011–2012 Pilot European Sentinel Registry. J Am Coll Cardiol . 2014;64(9):875–884. doi:10.1016/j.jacc.2014.06.1166.
  • Feldman T , Foster E , Glower DD , et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med . 2011;364(15):1395–1406. doi:10.1056/NEJMoa1009355.
  • Whitlow PL , Feldman T , Pedersen WR , et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol . 2012;59(2):130–139. doi:10.1016/j.jacc.2011.08.067.
  • Abello LMV , Klein AL , Marwick TH , et al. Understanding right ventricular dysfunction and functional tricuspid regurgitation accompanying mitral valve disease. J Thorac Cardiovasc Surg . 2013;145(5):1234–1241. e1235. doi:10.1016/j.jtcvs.2012.01.088.
  • Enriquez-Sarano M , Akins CW , Vahanian A . Mitral regurgitation. The Lancet . 2009;373(9672):1382–1394. doi:10.1016/S0140-6736(09)60692-9.
  • Douglas PS , Morrow R , Ioli A , Reichek N . Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol . 1989;13:311–315.
  • Tischler MD , Niggel J , Borowski DT , Lewinter MM . Relation between left ventricular shape and exercise capacity in patients with left ventricular dysfunction. J Am Coll Cardiol . 1993;22:751–757.
  • Reis Filho J , Cardoso JN , Cardoso C , Pereira-Barretto AC . Reverse cardiac remodeling: a marker of better prognosis in heart failure. Arq Bras Cardiol . 2015;104(6):502–506. doi:10.5935/abc.20150025.
  • Cioffi G , Stefenelli C , Tarantini L , Opasich C . Prevalence, predictors, and prognostic implications of improvement in left ventricular systolic function and clinical status in patients> 70 years of age with recently diagnosed systolic heart failure. Am J Cardiol . 2003;92:166–172.
  • Hellawell JL , Margulies KB . Myocardial reverse remodeling. Cardiovasc Ther . 2012;30(3):172–181. doi:10.1111/j.1755-5922.2010.00247.x.
  • Cleland JG , Daubert J-C , Erdmann E , et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med . 2005;352(15):1539–1549. doi:10.1056/NEJMoa050496.
  • Sutton MSJ , Ghio S , Plappert T , et al. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure. Circulation . 2009;120(19):1858–1865. doi:10.1161/CIRCULATIONAHA.108.818724.
  • Daubert C , Gold MR , Abraham WT , et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunct-ion: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol . 2009;54(20):1837–1846. doi:10.1016/j.jacc.2009.08.011.
  • Kainuma S , Taniguchi K , Toda K , et al. Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation. J Thorac Cardiovasc Surg . 2011;142(4):783–792. doi:10.1016/j.jtcvs.2010.11.031.
  • Le Tourneau T , Richardson M , Juthier F , et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart . 2010;96(16):1311–1317. doi:10.1136/hrt.2009.186486.
  • Patel H , Desai M , Tuzcu EM , Griffin B , Kapadia S . Pulmonary hypertension in mitral regurgitation. J Am Heart Assoc . 2014;3(4):e000748. doi:10.1161/JAHA.114.000844.
  • D’ascenzo F , Moretti C , Marra WG , et al. Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. Am J Cardiol . 2015;116(2):325–331. doi:10.1016/j.amjcard.2015.04.025.
  • Abraham WT , Fisher WG , Smith AL , et al. Cardiac resynchronization in chronic heart failure. N Engl J Med . 2002;346(24):1845–1853. doi:10.1056/NEJMoa013168.
  • Doughty RN , Whalley GA , Gamble G , MacMahon S , Sharpe N . Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol . 1997;29:1060–1066.
  • Cintron G , Johnson G , Francis G , Cobb F , Cohn JN . Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation . 1993;87:VI17–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.